Please assess the completion status of the following clinical trial:

Trial Title: Sodium Restriction in the Management of Cirrhotic Ascites

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Cirrhotic patients of any etiology with ascites from portal hypertension diagnosed by paracentesis,~* Age 18-75~* Clinical or radiographic (abdominal CT or ultrasound) estimate of moderate - severe ascites~* Spanish-speaking subjects will be eligible for participation~Exclusion Criteria:~* Active drug or alcohol abuse,~* Active complications of SBP, hepatic encephalopathy, or GI bleed within 2 weeks,~* Hemorrhagic ascites, malignant ascites,~* Creatinine \>2 mg/dL or CCl \< 30 mL/min,~* K \> 5.5 mmol/L,~* Diuretic refractory ascites~* Allergy to or intolerance of either spironolactone or furosemide~* Homelessness, incarceration, inability to follow up in clinic, or comply with diet.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): 4 gram sodium diet
- 2 (Type: ACTIVE_COMPARATOR): 2 gram sodium diet

Based on this trial design, predict the completion outcome and termination type (if applicable).